Heron Therapeutics (HRTX) Leases (2019 - 2025)
Historic Leases for Heron Therapeutics (HRTX) over the last 9 years, with Q3 2025 value amounting to $708000.0.
- Heron Therapeutics' Leases fell 7959.07% to $708000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $708000.0, marking a year-over-year decrease of 7959.07%. This contributed to the annual value of $2.8 million for FY2024, which is 4874.95% down from last year.
- Per Heron Therapeutics' latest filing, its Leases stood at $708000.0 for Q3 2025, which was down 7959.07% from $1.4 million recorded in Q2 2025.
- Heron Therapeutics' 5-year Leases high stood at $15.6 million for Q1 2021, and its period low was $708000.0 during Q3 2025.
- Its 5-year average for Leases is $7.0 million, with a median of $6.5 million in 2023.
- As far as peak fluctuations go, Heron Therapeutics' Leases tumbled by 1450.19% in 2021, and later crashed by 7959.07% in 2025.
- Over the past 5 years, Heron Therapeutics' Leases (Quarter) stood at $9.8 million in 2021, then decreased by 22.22% to $7.6 million in 2022, then decreased by 28.87% to $5.4 million in 2023, then crashed by 48.75% to $2.8 million in 2024, then tumbled by 74.6% to $708000.0 in 2025.
- Its last three reported values are $708000.0 in Q3 2025, $1.4 million for Q2 2025, and $2.1 million during Q1 2025.